Biesterfeld S, Veuskens U, Schmitz F J, Amo-Takyi B, Böcking A
Institute of Pathology, Technical University of Aachen, Germany.
Anticancer Res. 1996 Sep-Oct;16(5A):2497-500.
The interobserver reproducibility in the immunocyto-chemical assessment of estrogen- and progesterone receptor status was investigated in a series of 102 cases of primary breast carcinomas. Immunostaining was performed on 4 microns cryostat sections using estrogen- and progesterone immunocytochemical assays (ER-ICA and PR-ICA) with methylgreen counterstaining. The slides were evaluated independently by two observers. The proportion and staining intensity of ER- or PR-positive tumor cells in areas of invasive tumor growth was subjectively assessed based on the examination of the entire slide. Scoring was performed according to the proposals of Remmele and Reiner. Additionally, the cytosol estrogen- and progesterone receptor content was determined by a standard dextran-coated charcoal (DCC-) assay. Observer 1 interpreted 60 (59%) of the ER-stained specimens and 50 (49%) of the PR-stained specimens as receptor-positive; for observer 2 the respective values were 59 (58%) for ER-stained specimens and 51 (50%) for PR-stained specimens. Positive biochemical receptor status was found in 68 cases with the ER-DCC (67%) and in 47 with the PR-DCC (46%). The interobserver agreement between the two observers on the immunocytochemical receptor status was 89% for the estrogen receptor and 93% for the progesterone receptor 8.8% of the specimens were interpreted differently. Using the Remmele score, the concordance within the group of cases, which had been interpreted as receptor-positive by both observers, was 54% for the estrogen receptor and 57% for the progesterone receptor. The Reiner score showed concordant scorings of 72% for the estrogen receptor and 79% for the progesterone receptor. The present study indicates that complete agreement between scorings of different observers may not be expected, mainly due to differences in the interpretation of the specificity of staining and of the histological structures after immunostaining. The concordance of positive results using the three-graded Reiner score is comparable to that of the three-graded Bloom and Richardson grading system of breast cancer and reflects the limitation of subjective evaluation of morphology in general.
在102例原发性乳腺癌病例中,研究了雌激素和孕激素受体状态免疫细胞化学评估中的观察者间再现性。使用雌激素和孕激素免疫细胞化学检测(ER-ICA和PR-ICA)及甲基绿复染,对4微米厚的低温恒温器切片进行免疫染色。两名观察者独立评估切片。通过检查整个切片,主观评估浸润性肿瘤生长区域中ER或PR阳性肿瘤细胞的比例和染色强度。根据Remmele和Reiner的建议进行评分。此外,通过标准的葡聚糖包被活性炭(DCC)法测定胞质雌激素和孕激素受体含量。观察者1将60例(59%)ER染色标本和50例(49%)PR染色标本解释为受体阳性;观察者2对ER染色标本和PR染色标本的相应值分别为59例(58%)和51例(50%)。通过ER-DCC检测发现68例(67%)具有阳性生化受体状态,通过PR-DCC检测发现47例(46%)具有阳性生化受体状态。两名观察者在免疫细胞化学受体状态上的观察者间一致性,雌激素受体为89%,孕激素受体为93%。8.8%的标本解释不同。使用Remmele评分,在被两名观察者均解释为受体阳性的病例组中,雌激素受体的一致性为54%,孕激素受体的一致性为57%。Reiner评分显示雌激素受体的一致评分为72%,孕激素受体的一致评分为79%。本研究表明,不同观察者的评分可能无法完全一致,主要是由于免疫染色后对染色特异性和组织结构的解释存在差异。使用三级Reiner评分的阳性结果一致性与乳腺癌的三级Bloom和Richardson分级系统相当,总体上反映了形态学主观评估的局限性。